Share

EORTC abstracts selected at ESMO 2019

In total, EORTC will be presenting 3 abstracts (2 oral presentations and 1 poster) at the ESMO Congress 2019 from 27 September until 1 October in Barcelona, Spain.

Andrew Bottomley, Head of the Quality of Life at EORTC, will chair a session about “Surviving a cancer diagnosis with a good QoL” on 30 September from 8:30 to 10:00 and give a lecture on “Can value frameworks (such as ESMO-MCBS) contribute to a higher QoL?”

During the same session, Madeline Pe, EORTC Specialist in QoL, will talk about EORTC’s work on survivorship.

Meet us at our booth located in the society village n°20.

 

Oral presentations

A phase II study of Monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

R Galot, C Le Tourneau, E Saada-Bouzid, A Daste, C Even, P Debruyne, S Henry, S Zanetta, A Rutten, L Licitra, JL Canon, MC Kaminsky, P Specenier, S Rottey, L Dirix, T Raveloarivahy, C Fortpied, M Vanlancker, A Govaerts, JP Machiels  

Presentation number: 1109O

Speaker: Rachel Galot

Date: 30.09.2019 – Lecture time: 10:15 – 11:45 – Location: Cordoba Auditorium (Hall 7)

Redefining the IGCCCG Classification in advanced Non-Seminoma

Gillessen S, Collette L, Daugaard G, De Wit R, Tryakin A, Albany C, Stahl O, Fizazi K, Gietema J, De Giorgi U, Hansen AR,  Feldman D, Cafferty FH, Tandstad T, Garcia del Muro X, Huddart R, Sweeney C, Heng DY, Sauvé N and Beyer J for the IGCCCG Update Consortium

Presentation number: 903O

Speaker: Silke Gillessen

Date: 28.09.2019 – Lecture time: 15:30 – 15:45 – Location: Sevilla Auditorium (Hall 2)

 

Poster

There is a lack of clinical research for patients with cancer in palliative care

M. Vinches, A. Neven, L. Fenwarth, M. Terada, G. Rossi, S. Kelly, J. Peron, M. Thomaso, M. Groenvold, T. De Rojas

Poster number: 1610P

Poster presenter: Marie Vinches

Date: 28.09.2019 – Lecture time: 12:20 – Location: Poster Area (Hall 4)

Back to news list

Related News

  • EORTC participation at ISPOR Europe 2025 conference

  • EORTC Quality of Life Group participating at the ISOQOL 2025 Conference

  • New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research

  • EORTC celebrates the 100th anniversary of p-value on World Statistics Day

  • EORTC Announces Final Overall Survival Results from the PEACE-3 Trial

  • Results from EORTC trial define new standard of care for aggressive brain tumours

  • EORTC’s presence at ESMO 2025

  • EORTC’s presence at EANO 2025

  • EORTC celebrates Pink October: shaping the future of breast cancer care

  • EORTC shines a light on advancements in radioligand therapy